Barrett AD - Search Results

1

Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.

Barrett AD, Mathews JH, Miller BR, Medlen AR, Ledger TN, Roehrig JT. Barrett AD, et al. J Gen Virol. 1990 Jan;71 ( Pt 1):13-8. doi: 10.1099/0022-1317-71-1-13. J Gen Virol. 1990. PMID: 1689367

2

Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.

Sil BK, Dunster LM, Ledger TN, Wills MR, Minor PD, Barrett AD. Sil BK, et al. Among authors: barrett ad. J Virol. 1992 Jul;66(7):4265-70. doi: 10.1128/JVI.66.7.4265-4270.1992. J Virol. 1992. PMID: 1376368 Free PMC article.

3

Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.

Ledger TN, Sil BK, Wills MR, Lewis G, Kinney RM, Jennings AD, Stephenson JR, Barrett AD. Ledger TN, et al. Among authors: barrett ad. Biologicals. 1992 Jun;20(2):117-28. doi: 10.1016/s1045-1056(05)80059-4. Biologicals. 1992. PMID: 1389107

4

Yellow fever 17DD vaccine virus is temperature sensitive when grown in mosquito C6-36 cells.

Ledger TN, Sil BK, Dunster LM, Stephenson JR, Minor PD, Barrett AD. Ledger TN, et al. Among authors: barrett ad. Vaccine. 1992;10(10):652-4. doi: 10.1016/0264-410x(92)90084-w. Vaccine. 1992. PMID: 1523874

5

Attenuation of wild-type yellow fever virus by passage in HeLa cells.

Barrett AD, Monath TP, Cropp CB, Adkins JA, Ledger TN, Gould EA, Schlesinger JJ, Kinney RM, Trent DW. Barrett AD, et al. J Gen Virol. 1990 Oct;71 ( Pt 10):2301-6. doi: 10.1099/0022-1317-71-10-2301. J Gen Virol. 1990. PMID: 2230735

6

Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.

Barrett AD, Pryde A, Medlen AR, Ledger TN, Whitby JE, Gibson CA, DeSilva M, Groves DJ, Langley DJ, Minor PD. Barrett AD, et al. Vaccine. 1989 Aug;7(4):333-6. doi: 10.1016/0264-410x(89)90196-5. Vaccine. 1989. PMID: 2479185

7

Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus.

Vorndam V, Mathews JH, Barrett AD, Roehrig JT, Trent DW. Vorndam V, et al. Among authors: barrett ad. J Gen Virol. 1993 Dec;74 ( Pt 12):2653-60. doi: 10.1099/0022-1317-74-12-2653. J Gen Virol. 1993. PMID: 7506301

8

Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.

Ryman KD, Ledger TN, Weir RC, Schlesinger JJ, Barrett AD. Ryman KD, et al. Among authors: barrett ad. J Gen Virol. 1997 Jun;78 ( Pt 6):1353-6. doi: 10.1099/0022-1317-78-6-1353. J Gen Virol. 1997. PMID: 9191929

9

Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.

Ryman KD, Ledger TN, Campbell GA, Watowich SJ, Barrett AD. Ryman KD, et al. Among authors: barrett ad. Virology. 1998 Apr 25;244(1):59-65. doi: 10.1006/viro.1998.9057. Virology. 1998. PMID: 9581778 Free article.

10

Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.

Kinney RM, Esposito JJ, Johnson BJ, Roehrig JT, Mathews JH, Barrett AD, Trent DW. Kinney RM, et al. Among authors: barrett ad. J Gen Virol. 1988 Dec;69 ( Pt 12):3005-13. doi: 10.1099/0022-1317-69-12-3005. J Gen Virol. 1988. PMID: 2462013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters